“We seek to understand the molecular pathways that drive primary and metastatic brain tumors. Our goal is to identify new therapeutic targets that will help patients.”
-Priscilla Kaliopi Brastianos, MD
THE FIGHT AGAINST CANCER
The Central Nervous System Metastasis Program at Massachusetts General Hospital and Harvard Medical School, in collaboration with the Broad Institute of MIT and Harvard, has the following objectives:
(1) Identify and understand the molecular pathways driving brain metastases
(2) Identify novel therapeutic targets for patients with brain metastases
(3) Accelerate the application of our scientific findings to the clinical setting.
25 % of cancer patients that develop brain metastases
30 % of advanced HER2 positive breast cancers that develop brain metastases
40 % of advanced primary lung cancers that develop brain metastases
50 % of advanced triple negative breast cancers that develop brain metastases
50 % of advanced melanoma patients develop brain metastases
Brain Donation Program
A brain donation improves our understanding of these tumors and can enable research that leads to treatment innovations. It is also a chance for family and friends to learn more about their loved one’s tumor. We appreciate your consideration of this generous gift to research and to future patients.
More information can be found here: